-
Golimumab, sold
under the
brand name Simponi, is a
human monoclonal antibody which is used as an
immunosuppressive medication.
Golimumab targets tumor...
-
Calcipotriol plus
betamethasone dipropionate ointment.
Efalizumab Infliximab Golimumab Low dose
methotrexate Intralesional corticosteroid injection Available...
-
monoclonal antibody such as infliximab, adalimumab,
certolizumab pegol, and
golimumab, or with a
circulating receptor fusion protein such as etanercept. While...
- cytokines. Four
monoclonal antibodies (MAbs) (infliximab, adalimumab,
golimumab, and
certolizumab pegol) and one
recombinant TNF-α
decoy receptor, etanercept...
-
Infliximab as well as
other TNF
inhibitors like adalimumab, certolizumab, and
golimumab are
currently the most
common biologics used in the
treatment of both...
-
lacks this capability.
Other monoclonal antibodies targeting TNF-α are
golimumab, adalimumab, and
certolizumab pegol.
Etanercept also
binds and inhibits...
-
effectiveness when used
alone and
better results are
obtained when used together.
Golimumab is
effective when used with methotraxate. TNF
inhibitors may have equivalent...
-
combining Interleukin-2 and
Diphtheria toxin Interleukin-2
receptor binder golimumab Simponi rheumatoid arthritis,
psoriatic arthritis,
ankylosing spondylitis...
- drugs, such as etanercept, infliximab, adalimumab, certolizumab, and
golimumab,
target the
inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha)...
- anti-tumor
necrosis factor treatment (such as infliximab, etanercept,
golimumab, and adalimumab). In a
clinical trial cyclosporine added to prednisone...
